Burning Rock Biotech
28 hedge funds and large institutions have $20.1M invested in Burning Rock Biotech in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.08% less ownership
Funds ownership: 2.6% → 2.52% (-0.08%)
13% less funds holding
Funds holding: 32 → 28 (-4)
56% less capital invested
Capital invested by funds: $46.2M → $20.1M (-$26.1M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPU
Lansdowne Partners (UK)
London,
United Kingdom
|
+$191K |
| 2 |
Millennium Management
New York
|
+$53.6K |
| 3 |
EL
EWA LLC
Pittsbugh,
Pennsylvania
|
+$36.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.7K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$203 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$490K |
| 2 |
Barclays
London,
United Kingdom
|
-$373K |
| 3 |
Invesco
Atlanta,
Georgia
|
-$110K |
| 4 |
BlackRock
New York
|
-$63.3K |
| 5 |
State Street
Boston,
Massachusetts
|
-$63.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SNN
26
Shen Neil Nanpeng
| $858 | – | – | – |
|
27
JP Morgan Chase
New York
| $210 | – | – | – |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $169 | -$1.06K | -68 | -80% |
|
|
29
Invesco
Atlanta,
Georgia
| – | -$110K | -5,122 | Closed |
|
|
BA
30
Bridgewater Associates
Westport,
Connecticut
| – | -$36.5K | -1,675 | Closed |
|
|
VIA
31
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$32.9K | -1,532 | Closed |
|
|
PCM
32
Prelude Capital Management
New York
| – | -$29.2K | -1,358 | Closed |
|
33
Jane Street
New York
| – | -$22.4K | -1,041 | Closed |
|
|
SOW
34
State of Wyoming
Cheyenne,
Wyoming
| – | -$632 | -29 | Closed |
|
BNR Hedge Fund Activity: Q3 2023 in Review
28 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q3 2023, worth a combined $20.1M — down 56% from $46.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BNR and 2 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 3 added.
The largest buyer was Lansdowne Partners (UK), opening a new position worth an estimated $191K. The largest seller was Morgan Stanley, cutting an estimated $490K.
- 28 institutional investors held Burning Rock Biotech (BNR) as of Q3 2023, down from 32 in Q2 2023.
- Funds reported $20.1M of Burning Rock Biotech stock for Q3 2023, down 56% quarter-over-quarter.
- 2 funds opened new Burning Rock Biotech positions in Q3 2023 and 6 closed out, a net change of -4 holders.
- The largest Burning Rock Biotech buyer in Q3 2023 was Lansdowne Partners (UK), an estimated $191K added.
- The largest Burning Rock Biotech seller in Q3 2023 was Morgan Stanley, an estimated $490K sold.
Based on aggregated 13F filings for Q3 2023.